Science in service of something bigger
Patients deserve the best treatments possible.
At MFI, we apply our knowledge, software, and collaborative approach to advance discovery research and contribute to the development of life-changing therapies.
Meet the team
Our team spans medicinal, synthetic, and computational chemistry, CADD, machine learning, and software development. It is this mix of disciplines, experiences, and perspectives that allows MFI to approach complex discovery questions from more than one direction.
Operations

Josh Pottel, PhD
Chief Executive Officer (CEO)
+
Josh holds a PhD from McGill University and completed postdoctoral research at UCSF as an NRSA and CERSI fellow, where his research focused on software development in chemo- and bioinformatics. He is a co-inventor of The Virtual Chemist platform, which helped inform the scientific workflows of MFI's flagship platform, Canopy. Josh previously served as advisor for Arcadia Science, and currently serves on the Board of Directors of BIOQuébec and CQDM.
Outside of work, Josh is a proud father, a dedicated hockey fan (Go Habs go!), the owner of a 300 bowling game, and a San Francisco marathon finisher.

Nicolas Moitessier, PhD
Co-founder and Chief Scientific Officer (CSO)
+
Nic is a Full Professor at McGill University and a co-founder of Molecular Forecaster. He holds a PhD from Université Henri Poincaré-Nancy in France and completed postdoctoral research at UdM. His current interests include integrating computational chemistry, organic and medicinal chemistry, and software development. He has developed molecules as potential Parkinson's therapeutics that are currently at the pre-clinical stage, and he has been awarded the Fessenden Professorship in Innovation three times since 2007.
Nic has a twin brother, so if you’ve ever been sure you saw him in two places at once, you probably did.

Mihai Burai-Patrascu, PhD
Director of Product Strategy
+
Mihai holds a BSc in Chemistry from JUB in Germany and a PhD from McGill University in Canada, specializing in computational tools for organic and medicinal chemistry. His expertise includes drug design, cheminformatics, and software development. He holds two invention certificates and is a co-inventor on the Canopy patent, has received multiple awards and grants, and has published in journals including Nature Catalysis and JACS.
So far, Mihai has called four different countries home: Romania, Germany, England, and Canada.

Heena Punjabi, MBA
Director of Operations
+
Heena holds an MBA from the Indian Institute of Planning and Management and has over 10 years of experience in program and business operations, process improvement, and stakeholder engagement. Her background includes innovation programming and ESG research, with a focus on end-to-end execution, cross-functional coordination, and building systems that connect strategy to delivery. She also has experience in events, partnerships, and scaling operations across growing teams.
Heena is trained in Bharatanatyam, a classical Indian dance where expressions tell a story. She says that may be why her face often gives away what she’s thinking before she says a word.

Estrid Jakobsen, PhD
Director of Marketing and Communications
+
Estrid holds a PhD in Neuroscience from the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany, and completed postdoctoral research at the Montreal Neurological Institute-Hospital. Since transitioning from academia to science communications, she has acquired over seven years of experience in strategic communications, including roles at Conscience and the Quebec Bio-Imaging Network.
When she’s not at her desk, you might find Estrid walking her miniature dachshund, Pepper, singing in a choir, or tending to her many house plants.

PhD
Business Development Associate
+
Jathavan (Jath) holds a PhD from McGill University, where he focused on developing methods to deliver nucleic acid therapeutics for cancer treatment. His background spans experimental research and business development, with a specialization in building relationships with researchers and translating complex scientific concepts into practical solutions. He is passionate about bridging science and technology to empower researchers and accelerate innovation.
Outside of work, Jath is a serious board gamer who has travelled to Germany for Essen Spiel and is always looking to add to his collection of more than 100 games.
Science

Sébastien Alazet, PhD
Principal Scientist
+
Sébastien holds a PhD in organic chemistry from Université of Lyon 1 and completed postdoctoral research at EPFL Lausanne and the University of Toronto. His research focuses on medicinal chemistry from hit identification to lead optimization, with expertise in small-molecule design and synthesis and the integration of SAR and ADME properties into medicinal chemistry strategy. Before joining MFI, he worked as a medicinal chemist and chemistry lead at Nuchem Science, Evotec SA, and adMare Bioinnovation. He is a co-author of 17 peer-reviewed articles and one patent application, and he has received the Dina Surdin PhD Student Prize from the French Chemical Society’s Organic Chemistry Division and the DuPont Fluorine Chemistry PhD Student Award.
Sébastien is an avid cyclist and bikes to work every day, even in the harsh Québec winters.

Agathe Fayet, PhD
Principal Scientist
+
Agathe holds a PhD from Sorbonne Université and Ecole Polytechnique. Her research focuses on DFT and organic synthesis. She previously worked at the Broad Institute in Cambridge, Massachusetts, and completed an internship at McGill University under the supervision of Professor Nicolas Moitessier.

Ophélie Rostaing, MSc
Senior Scientist
+
Ophélie holds an MSc from Université de Paris in France. Her research focuses on structure-based drug design. She previously completed an internship at McGill University under the supervision of Professor Nicolas Moitessier.
If Ophélie could only eat one meal for the rest of her life, it would be cheese.

Matej Janezic, PhD
Senior Scientist
+
Matej holds a PhD from the University of Tokyo. His research focuses on structure- and ligand-based drug design. He previously worked at the National Institute of Chemistry in Slovenia.
Matej is a fan of bears of all types and is particularly passionate about polar bear encounters.

Anne Labarre, PhD
Senior Scientist
+
Anne holds a PhD in Chemistry and a BSc in Pharmacology from McGill University. Her research focuses on structure-based drug design and organic synthesis. She has worked in the Department of Pharmacology & Therapeutics at McGill University.
Ask Anne what she likes best about her work and she’ll say the tricky projects that challenge her, where she has to juggle several competing goals at once without letting the rest of the design slip, and work out which computational experiments bring the most value.

Guanyu (Chris) Wang, PhD
Senior Scientist
+
Chris holds a PhD in chemistry focused on SARS-CoV-2 protease inhibitors from McGill University, where he also completed postdoctoral training in the biophysics of oligonucleotides. He also has an MSc in computational and organic chemistry, focused on rational drug design, and a BSc in chemistry from the University of Manitoba.
Outside of work, you’re likely to find Chris tending to his collection of more than 150 plants, mostly orchids and ferns, as it takes him close to four hours every weekend to water them.

Shubham Ramgoolam, MSc
Scientist
+
Shubham holds an MSc in Pharmacy from the University of Waterloo’s School of Pharmacy, as well as an Honours Degree in Biochemistry (CSC Accredited) and a Joint Honours Degree in Mathematics from the University of Waterloo. His MITACS-funded MSc research emphasized machine learning, software development, and data analysis. Shubham graduated with Dean's Honours as an undergraduate, and his graduate work has produced two publications and two oral conference presentations.
If Shubham could live in a TV show for a day, he would choose Supernatural.

Benjamin Weiser
Research Fellow (Mitacs)
+
Ben is a PhD candidate at McGill University and holds a BSc Honours in physics and chemistry from Carleton University. After three years of particle physics research, he moved his focus to AI in chemistry, completing his honours thesis and now his PhD thesis on developing machine learning tools for therapeutic and molecular design applications. He has several publications to his name, with patents pending.
If Ben could only eat one meal for the rest of his life, it would be pizza.
Software

Mathieu Geoffroy
Senior Software Developer
+
Mathieu holds a BEng in Software Engineering from McGill University. His previous experience includes technical consulting at Deloitte and full-stack software development at CAE.
If Mathieu could only eat one meal for the rest of his life, it would be General Tao chicken.

Mathieu D'Onofrio
Senior Software Developer
+
Mathieu holds a BSc Honours in Computer Science from the University of Montreal and a technical DEC in computer science from CEGEP. His previous experience includes safety-critical embedded software at CMC, edge computing at RechoAI, robotics software at Omnirobotics, and C++ and CUDA software at CAE.
If Mathieu could only eat one meal for the rest of his life, it would likely be Margherita pizza as he says he craves it every day.

Jonah Zoldan
Associate Software Developer
+
Jonah holds a BSc in Computer Science and Biology from McGill University. His research focuses on machine learning for predicting off-target drug interactions. He previously worked in computational neuroscience research at the Montreal Neurological Institute (MNI).
Outside of work, you’re likely to find Jonah rehearsing for or performing in a musical.

Wasay Saeed
Associate Software Developer
+
Wasay holds a BSc in Computer Science and Bioinformatics from the University of Waterloo. He previously worked as a full-stack developer at PointClickCare, a backend developer at Toyota, and a software developer in test at Plooto.
Wasay’s favourite spot in Montreal is Panuozzo, which serves delicious Italian sandwiches and pizza.

Khadija Farah Gana
Associate Software Developer
+
Khadija holds a BSc in Computer Science and Statistics from McGill University and previously worked as a Research Assistant at the Institut de recherche en Immunologie et Cancérologie (IRIC).
Khadija’s favourite place to travel is home to Tunis, because of its people, sea, and delicious food.

Eva Otell
Junior Software Developer
+
Eva is a BEng student in Bioengineering at McGill University with a minor in Applied AI. She specializes in computational methods in bioengineering and biomedical engineering and has worked as an engineering intern at Bowhead Health and as an undergraduate research assistant between the Departments of Chemistry and Bioengineering.
If Eva could only eat one meal for the rest of her life, it would be sushi, or anything Sushiyo has to offer.
Our Advisors

Rebecca Swett, PhD
Advisor, Research & Technology
+
Rebecca (R.J.) is a Computational Chemist with over a decade of pharma experience. She holds a PhD from Wayne State University and completed a Presidential Postdoc at Novartis partnered with Stanford. R.J. has worked on rare disease and oncology targets at Vertex Pharmaceuticals and Relay Therapeutics. She is currently the Director of Computational Chemistry Innovation at X-Chem.

Didier Leconte, MBA
Advisor, Business Development & Finance
+
Didier is a seasoned investor and leader in the Canadian life sciences sector, with experience at Investissement Quebec and Fonds de solidarité FTQ. He has managed seed investment funds, collaborated with entrepreneurs, and advises life sciences clients. Didier holds an MBA in Technology Management and an engineering degree in Material Sciences.

Tamsin Mansley, PhD, CChem, CSci
Advisor, Product Strategy, Scientific Positioning, & Customer Adoption
+
Tamsin is Founder and Principal at Mansley Scientific, bringing 25 years of pattern recognition across science, software, and commercial leadership, from medicinal and computational chemistry through application science leadership to founding her own life sciences software strategy practice. She is the former President of Optibrium Inc. and Global Head of Application Science and has deep expertise in translating scientific software into solutions that integrate into real-world drug discovery workflows.
The company we keep
MFI works with discovery teams and organisations around the world. These relationships reflect the collaborative approach at the centre of how we work.
Our values
MFI has a strong, organically grown culture. Our values are reflected in how we approach the science, work with clients, and treat one another.
Integrity
We only take on projects where we believe we can contribute. We let the data speak for itself and prioritise honesty and accuracy in our research and reporting.
Transparency
We maintain open, ongoing communication with our clients. If we make a mistake, we acknowledge it.
Due Diligence
We approach our work with curiosity and thoroughness. We follow the evidence and do not leave important questions unanswered.
Collaboration
We bring together the knowledge, experience, and resources of our team and our clients to achieve the strongest possible results.
Scientific Contribution
We aim to advance or accelerate as many potential treatments as possible through our early-stage discovery model.
In our clients’ words
Bring a difficult question
If you are working through a complex small-molecule discovery challenge, talk to us about what your team is trying to understand, evaluate, or advance.





















